VolitionRx Limited announced its Nu.Q(R) Vet Cancer Test is now available for pre-order to veterinarians at the point-of-care through Heska Corporation (Heska). The Nu.Q(R) test will be showcased this weekend in Las Vegas at the 2023 Western Veterinary Conference. Heska's Nu.Q(R) Canine Cancer Screen and Monitor Test will operate on Heska's proprietary Element i+(R) Immunodiagnostic Analyzer, a point-of-care platform which provides veterinarians with rapid, accurate, low cost, and easy-to-use on-site testing in the veterinary clinic, to support clinical decision-making and improve patient outcomes.